Impact of the Niemann-Pick c1 Gene Mutation on the Total Cellular Glycomics of CHO Cells

被引:9
|
作者
Furukawa, Jun-ichi [1 ,4 ,5 ]
Soga, Minami [3 ]
Okada, Kazue [1 ,4 ,5 ]
Yokota, Ikuko [1 ,4 ,5 ]
Piao, Jinhua [1 ]
Irie, Tetsumi [3 ]
Era, Takumi [2 ]
Shinohara, Yasuro [1 ,6 ]
机构
[1] Hokkaido Univ, Grad Sch Adv Life Sci, Sapporo, Hokkaido 0010021, Japan
[2] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Cell Modulat, Kumamoto 8600811, Japan
[3] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Clin Chem & Informat, Kumamoto 8620973, Japan
[4] Hokkaido Univ, Fac Med, Dept Adv Clin Glycobiol, Sapporo, Hokkaido 0010021, Japan
[5] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido 0010021, Japan
[6] Kinjo Gakuin Univ, Dept Pharm, Nagoya, Aichi 4638521, Japan
关键词
Niemann-Pick disease; glycomics; N-glycan; O-glycan; glycosaminoglycan; glycosphingolipids; free oligosaccharide; cyclodextrin; DISEASE TYPE-C; N-GLYCOSYLATION; HEPARAN-SULFATE; STORAGE; IDENTIFICATION; ACCUMULATION; BIOMARKERS; MIGLUSTAT; TRANSPORT; CERAMIDE;
D O I
10.1021/acs.jproteome.7b00070
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Niemann-Pick disease type C (NPC) is an autosomal recessive lipid storage disorder, and the majority of cases are caused by mutations in the NPC1 gene. In this study, we clarified how a single gene mutation in the NPC1 gene impacts the cellular glycome by analyzing the total glycomic expression profile of Chinese hamster ovary cell mutants defective in the Npc1 gene (Npc1 KO CHO cells). A number of glycomic alterations were identified, including increased expression of lactosylceramide, GM1, GM2, GD1, various neolacto-series glycosphingolipids, and sialyl-T (O-glycan), which was found to be the major sialylated protein-bound glycan, as well as various N-glycans, which were commonly both fucosylated and sialylated. We also observed significant increases in the total amounts of free oligosaccharides (fOSs), especially in the unique complex- and hybrid-type fOSs. Treatment of Npc1 KO CHO cells with 2-hydroxypropyl-beta-cyclodextrin (HPBCD), which can reduce cholesterol and glycosphingolipid (GSL) storage, did not affect the glycomic alterations observed in the GSL-, N-, and O-glycans of Npc1 KO CHO cells. However, HPBCD treatment corrected the glycomic alterations observed in fOSs to levels observed in wild-type cells.
引用
收藏
页码:2802 / 2810
页数:9
相关论文
共 50 条
  • [21] Identification of cerebral spinal fluid protein biomarkers in Niemann-Pick disease, type C1
    Kiersten Campbell
    Niamh X. Cawley
    Rachel Luke
    Katelin E. J. Scott
    Nicholas Johnson
    Nicole Y. Farhat
    Derek Alexander
    Christopher A. Wassif
    Wenping Li
    Stephanie M. Cologna
    Elizabeth Berry-Kravis
    An Dang Do
    Ryan K. Dale
    Forbes D. Porter
    Biomarker Research, 11
  • [22] Main Olfactory and Vomeronasal Epithelium Are Differently Affected in Niemann-Pick Disease Type C1
    Witt, Martin
    Thiemer, Rene
    Meyer, Anja
    Schmitt, Oliver
    Wree, Andreas
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (11)
  • [23] Niemann-Pick C1 Functions Independently of Niemann-Pick C2 in the Initial Stage of Retrograde Transport of Membrane-impermeable Lysosomal Cargo
    Goldman, Stephen D. B.
    Krise, Jeffrey P.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (07) : 4983 - 4994
  • [24] Improvement in Lipid and Protein Trafficking in Niemann-Pick C1 Cells by Correction of a Secondary Enzyme Defect
    Devlin, Cecilia
    Pipalia, Nina H.
    Liao, Xianghai
    Schuchman, Edward H.
    Maxfield, Frederick R.
    Tabas, Ira
    TRAFFIC, 2010, 11 (05) : 601 - 615
  • [25] GEX1A, a Polyketide from Streptomyces chromofuscus, Corrects the Cellular Defects Associated with Niemann-Pick Type C1 in Human Fibroblasts
    Granatosky, Eve A.
    DiPrimio, Nina
    Pickering, Jarred R. E.
    Stevens, D. Cole
    Perlstein, Ethan O.
    Taylor, Richard E.
    JOURNAL OF NATURAL PRODUCTS, 2018, 81 (09): : 2018 - 2025
  • [26] Single Cell Transcriptome Analysis of Niemann-Pick Disease, Type C1 Cerebella
    Cougnoux, Antony
    Yerger, Julia C.
    Fellmeth, Mason
    Serra-Vinardell, Jenny
    Martin, Kyle
    Navid, Fatemeh
    Iben, James
    Wassif, Christopher A.
    Cawley, Niamh X.
    Porter, Forbes D.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (15) : 1 - 23
  • [27] Improved systemic AAV gene therapy with a neurotrophic capsid in Niemann-Pick disease type C1 mice
    Davidson, Cristin D.
    Gibson, Alana L.
    Gu, Tansy
    Baxter, Laura L.
    Deverman, Benjamin E.
    Beadle, Keith
    Incao, Arturo A.
    Rodriguez-Gil, Jorge L.
    Fujiwara, Hideji
    Jiang, Xuntian
    Chandler, Randy J.
    Ory, Daniel S.
    Gradinaru, Viviana
    Venditti, Charles P.
    Pavan, William J.
    LIFE SCIENCE ALLIANCE, 2021, 4 (10)
  • [28] A human iPSC-derived inducible neuronal model of Niemann-Pick disease, type C1
    Prabhu, Anika, V
    Kang, Insung
    De Pace, Raffaella
    Wassif, Christopher A.
    Fujiwara, Hideji
    Kell, Pamela
    Jiang, Xuntian
    Ory, Daniel S.
    Bonifacino, Juan S.
    Ward, Michael E.
    Porter, Forbes D.
    BMC BIOLOGY, 2021, 19 (01)
  • [29] Neurological Dysfunction in Early Maturity of a Model for Niemann-Pick C1 Carrier Status
    Hung, Ya Hui
    Walterfang, Mark
    Churilov, Leonid
    Bray, Lisa
    Jacobson, Laura H.
    Barnham, Kevin J.
    Jones, Nigel C.
    O'Brien, Terence J.
    Velakoulis, Dennis
    Bush, Ashley I.
    NEUROTHERAPEUTICS, 2016, 13 (03) : 614 - 622
  • [30] Potential Disease-Modifying Effects of Lithium Carbonate in Niemann-Pick Disease, Type C1
    Han, Shiqian
    Zhang, Huiwen
    Yi, Mengni
    Liu, Xiaoqing
    Maegawa, Gustavo H. B.
    Zou, Yunding
    Wang, Qijun
    Wu, Dianqing
    Ye, Zhijia
    FRONTIERS IN PHARMACOLOGY, 2021, 12